These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
127 related articles for article (PubMed ID: 12082622)
1. Loss of Stat5a delays mammary cancer progression in a mouse model. Ren S; Cai HR; Li M; Furth PA Oncogene; 2002 Jun; 21(27):4335-9. PubMed ID: 12082622 [TBL] [Abstract][Full Text] [Related]
2. Possible role of Stat5a in rat mammary gland carcinogenesis. Shan L; Yu M; Clark BD; Snyderwine EG Breast Cancer Res Treat; 2004 Dec; 88(3):263-72. PubMed ID: 15609129 [TBL] [Abstract][Full Text] [Related]
3. WAP-TAg transgenic mice and the study of dysregulated cell survival, proliferation, and mutation during breast carcinogenesis. Li M; Lewis B; Capuco AV; Laucirica R; Furth PA Oncogene; 2000 Feb; 19(8):1010-9. PubMed ID: 10713684 [TBL] [Abstract][Full Text] [Related]
4. Signal transducer and activator of transcription 5a influences mammary epithelial cell survival and tumorigenesis. Humphreys RC; Hennighausen L Cell Growth Differ; 1999 Oct; 10(10):685-94. PubMed ID: 10547072 [TBL] [Abstract][Full Text] [Related]
5. Overexpression and forced activation of stat5 in mammary gland of transgenic mice promotes cellular proliferation, enhances differentiation, and delays postlactational apoptosis. Iavnilovitch E; Groner B; Barash I Mol Cancer Res; 2002 Nov; 1(1):32-47. PubMed ID: 12496367 [TBL] [Abstract][Full Text] [Related]
6. Functional rescue of Stat5a-null mammary tissue through the activation of compensating signals including Stat5b. Liu X; Gallego MI; Smith GH; Robinson GW; Hennighausen L Cell Growth Differ; 1998 Sep; 9(9):795-803. PubMed ID: 9751123 [TBL] [Abstract][Full Text] [Related]
7. Haploid loss of Ki-ras delays mammary tumor progression in C3 (1)/SV40 Tag transgenic mice. Liu ML; Shibata MA; Von Lintig FC; Wang W; Cassenaer S; Boss GR; Green JE Oncogene; 2001 Apr; 20(16):2044-9. PubMed ID: 11360188 [TBL] [Abstract][Full Text] [Related]
9. Activation of signal transducer and activator of transcription 5 is required for progression of autochthonous prostate cancer: evidence from the transgenic adenocarcinoma of the mouse prostate system. Kazansky AV; Spencer DM; Greenberg NM Cancer Res; 2003 Dec; 63(24):8757-62. PubMed ID: 14695191 [TBL] [Abstract][Full Text] [Related]
10. Metastasis tumor antigen family proteins during breast cancer progression and metastasis in a reliable mouse model for human breast cancer. Zhang H; Stephens LC; Kumar R Clin Cancer Res; 2006 Mar; 12(5):1479-86. PubMed ID: 16533771 [TBL] [Abstract][Full Text] [Related]
11. HBX causes cyclin D1 overexpression and development of breast cancer in transgenic animals that are heterozygous for p53. Klein A; Guhl E; Tzeng YJ; Fuhrhop J; Levrero M; Graessmann M; Graessmann A Oncogene; 2003 May; 22(19):2910-9. PubMed ID: 12771941 [TBL] [Abstract][Full Text] [Related]
12. p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cabodi S; Tinnirello A; Di Stefano P; Bisarò B; Ambrosino E; Castellano I; Sapino A; Arisio R; Cavallo F; Forni G; Glukhova M; Silengo L; Altruda F; Turco E; Tarone G; Defilippi P Cancer Res; 2006 May; 66(9):4672-80. PubMed ID: 16651418 [TBL] [Abstract][Full Text] [Related]
13. Stat5a is essential for the proliferation and survival of murine mast cells. Ikeda K; Nakajima H; Suzuki K; Watanabe N; Kagami S; Iwamoto I Int Arch Allergy Immunol; 2005; 137 Suppl 1():45-50. PubMed ID: 15947484 [TBL] [Abstract][Full Text] [Related]
14. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells. Yamashita H; Iwase H; Toyama T; Fujii Y Oncogene; 2003 Mar; 22(11):1638-52. PubMed ID: 12642867 [TBL] [Abstract][Full Text] [Related]
15. Constitutive activation of Stat5b contributes to carcinogenesis in vivo. Xi S; Zhang Q; Gooding WE; Smithgall TE; Grandis JR Cancer Res; 2003 Oct; 63(20):6763-71. PubMed ID: 14583472 [TBL] [Abstract][Full Text] [Related]
16. Reduced mammary tumor progression in WAP-TAg/WAP-maspin bitransgenic mice. Zhang M; Shi Y; Magit D; Furth PA; Sager R Oncogene; 2000 Dec; 19(52):6053-8. PubMed ID: 11146557 [TBL] [Abstract][Full Text] [Related]
17. Protease activity of urokinase and tumor progression in a syngeneic mammary cancer model. Merchan JR; Tang J; Hu G; Lin Y; Mutter W; Tong C; Karumanchi SA; Russell SJ; Sukhatme VP J Natl Cancer Inst; 2006 Jun; 98(11):756-64. PubMed ID: 16757700 [TBL] [Abstract][Full Text] [Related]
18. The role of Ink4a/Arf in ErbB2 mammary gland tumorigenesis. D'Amico M; Wu K; Di Vizio D; Reutens AT; Stahl M; Fu M; Albanese C; Russell RG; Muller WJ; White M; Negassa A; Lee HW; DePinho RA; Pestell RG Cancer Res; 2003 Jun; 63(12):3395-402. PubMed ID: 12810676 [TBL] [Abstract][Full Text] [Related]
19. Loss of anti-mitotic effects of Bcl-2 with retention of anti-apoptotic activity during tumor progression in a mouse model. Furth PA; Bar-Peled U; Li M; Lewis A; Laucirica R; Jäger R; Weiher H; Russell RG Oncogene; 1999 Nov; 18(47):6589-96. PubMed ID: 10597263 [TBL] [Abstract][Full Text] [Related]